RR

Rogier Rooswinkel

General Partner at Forbion

Heemstede, North Holland

Overview

Work Experience

Forbion - Impacting the future of medicine

  • General Partner

    2013 - Current

Netherlands Cancer Institute

  • Postdoc

    2013 - 2013

  • PhD-student

    2008 - 2013

KlachtenCentrale

  • Owner

    2005 - 2007

Vm

VU medical Centre

  • Technician and programmer

    2003 - 2007

Education

Investments

Pheon Therapeutics

Series A

Total Funding: $190M

Tessellate BIO

Seed

Total Funding: $8M

CatalYm

Series C

Total Funding: $200M

Amphista Therapeutics

Series B

Total Funding: $61M

Relevant Websites